With the new capital infusion, Sanofi Ventures’ total assets under management now tops $1.4 billion. Our recap of other financings includes startups raising money for novel therapies in development for autoimmune disease, neurological disorders, cancer, and more.
The post Sanofi Pumps $625M Into Venture Arm to Back Breakthroughs in Early-Stage Startups appeared first on MedCity News.
